Kraig Biocraft Laboratories (KBLB) Cash from Operations (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Cash from Operations across 16 years of filings, most recently posting 449487.0 for Q4 2025.

• Cash from Operations for Q4 2025 came in at 449487.0, up 12.3% year-over-year; the trailing twelve-month figure through Dec 2025 was 1788970.0 (up 2.73% YoY), and the FY2025 annual result was 1788970.0, up 2.73% from the prior year.
• Cash from Operations came in at 449487.0 for Q4 2025 at Kraig Biocraft Laboratories, up from 461859.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 248718.0 in Q3 2023 to a low of 548152.0 in Q2 2021.
• The 5-year median for Cash from Operations is 442359.5 (2022), against an average of 428026.75.
• Across the five-year window, Cash from Operations jumped 48.77% in 2023 and tumbled 87.38% in 2024, its largest moves.
• Kraig Biocraft Laboratories' Cash from Operations stood at 395150.0 in 2021, then fell by 11.75% to 441594.0 in 2022, then increased by 25.79% to 327721.0 in 2023, then slumped by 56.39% to 512523.0 in 2024, then increased by 12.3% to 449487.0 in 2025.
• The last three Cash from Operations figures came in at 449487.0 (Q4 2025), 461859.0 (Q3 2025), and 443125.0 (Q2 2025), per Business Quant data.